Navigation Links
Cocoon Biotech Announces CEO, Dr. Ailis Tweed-Kent, Named to Boston Business Journal's "2017 Women to Watch in Science and Technology" List
Date:2/16/2017

BOSTON, Feb. 16, 2017 /PRNewswire/ -- Cocoon Biotech, Inc., a biotechnology company focused on the development of osteoarthritis and other drug-delivery therapies based on its silk protein technology, has announced that Cocoon Founder and CEO, Ailis Tweed-Kent, M.D., has been named by the Boston Business Journal as one of the "2017 Women to Watch in Science and Technology" winners.

The journal has named Dr. Tweed-Kent as one of the ten recipients and according to the journal, "recognizes New England's female technology and business leaders; the innovators who are helping to build new companies and drive established tech companies in new directions." The honorees will be recognized today at the 14th Annual Women to Watch Awards Breakfast in Boston.

"I am honored, humbled and thankful to be named as a leader in this field of incredibly bright women who are each committed to making important advances in their respective areas of science and technology," stated Dr. Tweed-Kent. "My hope is that the important work that we are doing at Cocoon Biotech will ultimately improve the lives of thousands of patients worldwide who are suffering from osteoarthritis."

About Cocoon Biotech, Inc.
Cocoon Biotech was founded in 2013 to bring treatments for arthritis and other debilitating diseases to market. Cocoon Biotech's platform technology is a biocompatible silk protein that can be loaded with small molecule or protein therapeutics and injected into joints to provide effective, long-lasting pain relief and potentially delay the progression of disease. This platform will leverage several unique properties of the silk protein fibroin, including strength and biocompatibility. For more information, please visit www.cocoonbiotech.com.

Contact:
Jennifer Williams
Cook Williams Communications, Inc.
650-315-3538
jennifer@cwcomm.org

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cocoon-biotech-announces-ceo-dr-ailis-tweed-kent-named-to-boston-business-journals-2017-women-to-watch-in-science-and-technology-list-300408629.html


'/>"/>
SOURCE Cocoon Biotech, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. FinancialBuzz.com: Developments in the Biotechnology Market
2. White Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
3. Fast Company Honors Braeburn Pharmaceuticals as a Top Ten Most Innovative Company in Biotech
4. Technical Reports on Biotech Stocks -- Progenics Pharma, Intrexon, Synthetics Biologics, and 22nd Century
5. The Biotech Market Grows as Demand for New Therapeutics Increases
6. Biotech Stocks Under Scanner -- Mast Therapeutics, MannKind, Celgene, and Opko Health
7. Diplomat Completes Acquisition of Affinity Biotech
8. Global Nanobiotechnology Applications, Markets and Companies Report 2017-2020 & 2025: Profiles of 250+ Companies with Their 180 Collaborations - Research and Markets
9. Global Smart Inhalers Market Analysis & Trends 2017-2025: Recent R&D Programs by Top Players in Pharmaceutical and Biotechnological Industries - Research and Markets
10. Research Reports Initiation on Biotech Stocks -- Portola Pharma, Tesaro, Sangamo Therapeutics, and Cerus
11. FinancialBuzz.com: Advances in Technology Applied in the Biotech Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology:
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):